Shenoy Mohan, Chapman Carrie B, Nawaz M Zaim, Sweitzer Nancy K
Department of Medicine, University of Wisconsin, Madison, WI 53792-3220, USA.
Congest Heart Fail. 2006 May-Jun;12(3):146-52. doi: 10.1111/j.1527-5299.2006.04621.x.
Reduction of the monetary and societal costs of the heart failure epidemic can best be achieved by prevention of new heart failure cases. To effectively prevent heart failure, patients at risk must be identified and treated. The American College of Cardiology/American Heart Association Guidelines for Evaluation and Management of Chronic Heart Failure in the Adult define the stage A heart failure patient as one with identified risk factors for heart failure, particularly coronary heart disease, hypertension, and diabetes, but no evidence of cardiovascular damage. In this review, the authors discuss the commonly recognized, as well as some less commonly recognized, risk factors that define the stage A patient. The authors also discuss data demonstrating that risk factor modification can reduce heart failure incidence. Given the size of the population at risk, through increased awareness of heart failure risk and aggressive treatment, health care providers can critically impact this public health concern.
降低心力衰竭流行所带来的金钱和社会成本,最佳途径是预防新的心力衰竭病例。为有效预防心力衰竭,必须识别并治疗有风险的患者。美国心脏病学会/美国心脏协会《成人慢性心力衰竭评估与管理指南》将A期心力衰竭患者定义为有心力衰竭风险因素,特别是冠心病、高血压和糖尿病,但无心血管损伤证据的患者。在本综述中,作者讨论了定义A期患者的常见以及一些不太常见的风险因素。作者还讨论了表明风险因素修正可降低心力衰竭发病率的数据。鉴于有风险人群的规模,通过提高对心力衰竭风险的认识和积极治疗,医疗保健提供者可对这一公共卫生问题产生重大影响。